3--4--7-trihydroxyisoflavone and daidzein

3--4--7-trihydroxyisoflavone has been researched along with daidzein* in 6 studies

Reviews

1 review(s) available for 3--4--7-trihydroxyisoflavone and daidzein

ArticleYear
Isolation, bioactivity, and production of ortho-hydroxydaidzein and ortho-hydroxygenistein.
    International journal of molecular sciences, 2014, Apr-03, Volume: 15, Issue:4

    Daidzein and genistein are two major components of soy isoflavones. They exist abundantly in plants and possess multiple bioactivities. In contrast, ortho-hydroxydaidzein (OHD) and ortho-hydroxygenistein (OHG), including 6-hydroxydaidzein (6-OHD), 8-hydroxydaidzein (8-OHD), 3'-hydroxydaidzein (3'-OHD), 6-hydroxygenistein (6-OHG), 8-hydroxygenistein (8-OHG), and 3'-hydroxygenistein (3'-OHG), are rarely found in plants. Instead, they are usually isolated from fermented soybean foods or microbial fermentation broth feeding with soybean meal. Accordingly, the bioactivity of OHD and OHG has been investigated less compared to that of soy isoflavones. Recently, OHD and OHG were produced by genetically engineering microorganisms through gene cloning of cytochrome P450 (CYP) enzyme systems. This success opens up bioactivity investigation and industrial applications of OHD and OHG in the future. This article reviews isolation of OHD and OHG from non-synthetic sources and production of the compounds by genetically modified microorganisms. Several bioactivities, such as anticancer and antimelanogenesis-related activities, of OHD and OHG, are also discussed.

    Topics: Aspergillus; Cytochrome P-450 Enzyme System; Genistein; Glycine max; Isoflavones; Neoplasms; Soy Foods

2014

Other Studies

5 other study(ies) available for 3--4--7-trihydroxyisoflavone and daidzein

ArticleYear
7,3',4'-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species.
    Toxicology, 2012, Dec-16, Volume: 302, Issue:2-3

    The development of multidrug resistance (MDR) to conventional chemoradiation therapy usually leads to failure in treating cervical cancer. This study aims to explore the effects and mechanisms of 7,3',4'-trihydroxyisoflavone (7,3',4'-THIF), one of the major metabolites of daidzein, on potentiating cytotoxicity of epirubicin (Epi), an anticancer drug in human cervical cancer HeLa cells. The cytotoxicity of Epi remarkably increased when it was combined with 7,3',4'-THIF. The cotreatment increased the reactive oxygen species (ROS) levels, including hydrogen peroxide and superoxide free radicals. 7,3',4'-THIF was shown to down-regulate the MDR1 promoter region composed of the elements of AP1, GC-box, and Y-box, as demonstrated by a luciferase assay. A negative regulation of hMDR1 gene with multiple transcription factors by this isoflavone may provide a novel molecular mechanism for MDR modulation. The mRNA expressions of MDR1, MDR-associated protein (MRP) 1, and MRP2 for the combined treatment were significantly lower than those of the Epi treatment. This result implies that MDR transporter-mediated Epi resistance is inhibited at various degrees by the addition of 7,3',4'-THIF. This isoflavone significantly enhanced intracellular Epi accumulation in HeLa cells. 7,3',4'-THIF and/or Epi triggered apoptosis through the upregulation of p53, Bax, and caspase-9. Apoptosis induction was also confirmed by the reduced mitochondrial membrane potential, increased sub-G1 and G2/M phases, nuclear DNA fragmentation, and chromatin condensation. Our findings demonstrate for the first time that 7,3',4'-THIF causes cell death in human cervical cancer cells through the ROS-dependent suppression of MDR transporters and p53-mediated activation of the intrinsic mitochondrial pathway of apoptosis. Thus, 7,3',4'-THIF has the potential to enhance the activity of a broad range of cancer chemotherapeutics in the MDR spectrum with the advantage of reducing adverse effects.

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Caspase 9; DNA Fragmentation; Drug Resistance, Neoplasm; Epirubicin; HeLa Cells; Humans; Isoflavones; Mitochondria; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Promoter Regions, Genetic; Reactive Oxygen Species; Tumor Suppressor Protein p53; Up-Regulation

2012
7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4.
    The Journal of biological chemistry, 2011, Apr-22, Volume: 286, Issue:16

    Nonmelanoma skin cancer is one of the most frequently occurring cancers in the United States. Chronic exposure to UVB irradiation is a major cause of this cancer. Daidzein, along with genistein, is a major isoflavone found in soybeans; however, little is known about the chemopreventive effects of daidzein and its metabolites in UVB-induced skin cancer. Here, we found that 7,3',4'-trihydroxyisoflavone (THIF), a major metabolite of daidzein, effectively inhibits UVB-induced cyclooxygenase 2 (COX-2) expression through the inhibition of NF-κB transcription activity in mouse skin epidermal JB6 P+ cells. In contrast, daidzein had no effect on COX-2 expression levels. Data from Western blot and kinase assays showed that 7,3',4'-THIF inhibited Cot and MKK4 activity, thereby suppressing UVB-induced phosphorylation of mitogen-activated protein kinases. Pull-down assays indicated that 7,3',4'-THIF competed with ATP to inhibit Cot or MKK4 activity. Topical application of 7,3',4'-THIF clearly suppressed the incidence and multiplicity of UVB-induced tumors in hairless mouse skin. Hairless mouse skin results also showed that 7,3',4'-THIF inhibits Cot or MKK4 kinase activity directly, resulting in suppressed UVB-induced COX-2 expression. A docking study revealed that 7,3',4'-THIF, but not daidzein, easily docked to the ATP binding site of Cot and MKK4, which is located between the N- and C-lobes of the kinase domain. Collectively, these results provide insight into the biological actions of 7,3',4'-THIF, a potential skin cancer chemopreventive agent.

    Topics: Animals; Cyclooxygenase 2; Gene Expression Regulation, Neoplastic; Glycine max; Isoflavones; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Mice; Mice, Inbred ICR; Neoplasms, Radiation-Induced; NF-kappa B; Plant Extracts; Proto-Oncogene Proteins; Signal Transduction; Skin Neoplasms; Ultraviolet Rays

2011
Effects of riboflavin photosensitization on daidzein and its photosensitized derivatives.
    Journal of food science, 2010, Volume: 75, Issue:8

    Photosensitized compounds from daidzein were studied in a riboflavin model system under visible light irradiation by high-performance liquid chromatography (HPLC). As the period of light irradiation increased, concentration of daidzein decreased significantly (P < 0.05) and new peaks of daidzein derivatives were observed and changed during photosensitization. Three new peaks from photosensitized daidzein were tentatively identified as 7-, 3', 4'-trihydroxyisoflavone (or 3'-hydroxydaidzein) and 2 dimmers of daidzein by a combination of HPLC-mass spectrometry (MS) and retention times of standard compounds by HPLC. Addition of sodium azide and removal of headspace oxygen treatment affected the formation of newly formed peaks. The type I pathway of riboflavin photosensitization played more important roles than type II pathways on the formation of daidzein derivatives. Practical Application: Isoflavones are important phytochemicals found in soy foods. Generally, many foods containing soy ingredients are displayed under visible light irradiation. Also, riboflavin can be found in many foods containing vegetables. The results of this study can be used to understand the stability and changes of isoflavone aglycones in soy and soy-based foods under visible light irradiation.

    Topics: Chromatography, High Pressure Liquid; Dimerization; Free Radical Scavengers; Isoflavones; Light; Models, Chemical; Osmolar Concentration; Oxidation-Reduction; Oxygen; Photosensitizing Agents; Riboflavin; Singlet Oxygen; Sodium Azide; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Time Factors

2010
Isoflavone daidzein possesses no antioxidant activities in cell-free assays but induces the antioxidant enzyme catalase.
    Nutrition research (New York, N.Y.), 2008, Volume: 28, Issue:9

    Epidemiologic studies have shown that dietary intake of isoflavonones is associated with several properties beneficial to human health. It has been suggested that at least some of these effects are related to the antioxidant activity of isoflavonoids. We analyzed the antioxidant activity of the major isoflavones found in soybeans, but none of these compounds showed prominent antioxidant effects in cell-free assay systems (trolox equivalent antioxidant capacity assay and 2,2-diphenyl-1-picrylhydrazyl assay). Therefore, we examined the hypothesis that the antioxidative effects of isoflavones are caused indirectly by up-regulation of antioxidative enzymes, thereby lowering intracellular concentration of reactive oxygene species. Daidzein shows a significant induction of catalase promoter activity at 100 micromol/L in a reporter gene assay and at 200 micromol/L in Northern blot experiments. Another hypothesis for antioxidant effects caused by isoflavones is due to metabolism by intestinal bacteria. Analyzing the daidzein metabolites 3'-OH-daidzein and 6-OH-daidzein in our cell culture model, we found strong antioxidant effects (2,2-diphenyl-1-picrylhydrazyl and trolox equivalent antioxidant capacity assay). We conclude that isoflavone daidzein up-regulates the antioxidant enzyme catalase but shows only little antioxidant capacity per se. Antioxidant effects of this dietary isoflavonone may also be due to formation of the antioxidant metabolites 6-OH-daidzein and 3'-OH-daidzein.

    Topics: Animals; Antioxidants; Catalase; Cell Line, Tumor; Cell-Free System; Cytochrome P-450 Enzyme System; Enzyme Induction; Glycine max; Isoflavones; Liver Neoplasms, Experimental; Phaseolus; Rats; Seeds

2008
Urinary metabolites of daidzin orally administered in rats.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:9

    In a study on the metabolism of flavonoids, the isoflavone glycoside daidzin was orally administered to rats. Urine samples were collected and treated with beta-glucuronidase and arylsulfatase. Aglycone daidzein (M3) and other three metabolites, 3',4',7-trihydroxyisoflavone (M1), 4',7-dihydroxyisoflavanone (M2) and 4',7-dihydroxyisoflavan (M4) were isolated from the urine following treatment with enzymes. The structures of M1, M2 and M4 were determined on the basis of chemical and spectral data.

    Topics: Administration, Oral; Animals; Arylsulfatases; Chromans; Chromatography, High Pressure Liquid; Equol; Glucuronidase; Isoflavones; Male; Rats; Rats, Sprague-Dawley

1998